These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2285498)

  • 21. High-dose methotrexate with a safe rescue program.
    Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
    Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcoal haemoperfusion and methotrexate toxicity.
    Bouffet E; Frappaz D; Laville M; Finaz J; Pinkerton CR; Philip T; Brunat-Mentigny M
    Lancet; 1986 Jun; 1(8496):1497. PubMed ID: 2873302
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of charcoal hemoperfusion and hemodialysis in the treatment of methotrexate toxicosis in a dog.
    Pardo M; Lanaux T; Davy R; Bandt C
    J Vet Emerg Crit Care (San Antonio); 2018 May; 28(3):269-273. PubMed ID: 29727524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate clearance and clinical toxicity in osteosarcoma following high-dose methotrexate therapy.
    Iqbal MP; Khursheed M; Mahboobali N
    J Pak Med Assoc; 1989 Feb; 39(2):38-42. PubMed ID: 2499702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of hemodialysis in a case of acute methotrexate poisoning].
    Gauthier E; Gimonet JF; Piedbois P; Rostoker G; Buisson C; Ben Maadi A; Samyn B; Messadi AA; Brun B; Feuilhade F
    Presse Med; 1990 Dec 22-29; 19(44):2023-5. PubMed ID: 2148614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.
    Jaffe N; Prudich J; Knapp J; Wang YM; Bowman R; Cangir A; Ayala A; Chuang V; Wallace S
    J Clin Oncol; 1983 Jul; 1(7):428-31. PubMed ID: 6607977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vincristine in the etiology of toxicity of high-dose methotrexate therapy.
    Ridgway D; Renholds DC; Neerhout RC; Wolff LJ
    Cancer; 1980 Dec; 46(12):2571-2. PubMed ID: 6969624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of high-dose methotrexate after intravenous administration in Chinese osteosarcoma patients from a single institution.
    Zhang W; Zhang Q; Tian X; Zhao H; Lu W; Zhen J; Niu X
    Chin Med J (Engl); 2015 Jan; 128(1):111-8. PubMed ID: 25563323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
    Cohen HJ; Jaffe N
    Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available.
    Rosales A; Madrid A; Muñoz M; Dapena JL; Ariceta G
    Front Pediatr; 2021; 9():635152. PubMed ID: 34490152
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
    Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
    Titier K; Lagrange F; Péhourcq F; Moore N; Molimard M
    Ther Drug Monit; 2002 Aug; 24(4):570-2. PubMed ID: 12142645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate poisoning with acute hepatorenal dysfunction.
    Goto E; Tomojiri S; Okamoto I; Tanaka K
    J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.